0001914060-22-000002.txt : 20220902 0001914060-22-000002.hdr.sgml : 20220902 20220902112249 ACCESSION NUMBER: 0001914060-22-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220902 DATE AS OF CHANGE: 20220902 EFFECTIVENESS DATE: 20220902 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Biolexis Therapeutics, Inc. CENTRAL INDEX KEY: 0001914060 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-457825 FILM NUMBER: 221223896 BUSINESS ADDRESS: STREET 1: 9980 SOUTH, 300 WEST, SUITE #200 CITY: SANDY STATE: UT ZIP: 84070 BUSINESS PHONE: 801-550-8088 MAIL ADDRESS: STREET 1: 9980 SOUTH, 300 WEST, SUITE #200 CITY: SANDY STATE: UT ZIP: 84070 D 1 primary_doc.xml X0708 D LIVE 0001914060 Biolexis Therapeutics, Inc. 9980 SOUTH, 300 WEST, SUITE #200 SANDY UT UTAH 84070 801-550-8088 DELAWARE None None Corporation true 2021 Dr. David J. Bearss 9980 South 300 West Suite 200 Sandy UT UTAH 84070 Executive Officer Dr. Hariprasad Vankayalapati 9980 South 300 West Suite 200 Sandy UT UTAH 84070 Executive Officer David O. Taylor 9980 South 300 West Suite 200 Sandy UT UTAH 84070 Executive Officer Biotechnology Decline to Disclose 06b false 2022-08-18 false true false 0 Indefinite 1500000 Indefinite false 2 0 0 0 false Biolexis Therapeutics, Inc. David O. Taylor David O. Taylor CFO 2022-09-02